PFO: Active Implantable Bone Conduction Hearing System
FDA product code PFO: Active Implantable Bone Conduction Hearing System. View classification details, related manufacturers, 510(k) clearances, and recall records.
An active implantable bone conduction hearing system is a prescription device consisting of an implanted transducer, implanted electronics components, and an audio processor. The active implantable bone conduction hearing system is intended to compensate for conductive or mixed hearing losses by conveying amplified acoustic signals to the cochlea via mechanical vibrations on the skull bone.
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope
11 clearance records and 0 recall records in the covered releases, across 4 source company names and 1 product codes. Dated history runs from Mar 7, 2019 to Jul 10, 2026.
All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.